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ULK1 phosphorylates Exo70 to suppress breast
cancer metastasis
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Increased expression of protein kinase ULK1 was reported to negatively correlate with breast
cancer metastasis. Here we report that ULK1 suppresses the migration and invasion of human
breast cancer cells. The suppressive effect is mediated through direct phosphorylation of
Exo70, a key component of the exocyst complex. ULK1 phosphorylation inhibits Exo70 homo-
oligomerization as well as its assembly to the exocyst complex, which are needed for cell
protrusion formation and matrix metalloproteinases secretion during cell invasion. Reversely,
upon growth factor stimulation, Exo70 is phosphorylated by ERK1/2, which in turn sup-
presses its phosphorylation by ULK1. Together, our study identifies Exo70 as a substrate of
ULK1 that inhibits cancer metastasis, and demonstrates that two counteractive regulatory
mechanisms are well orchestrated during tumor cell invasion.
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Breast cancer is among the most prevalent cancers and thefirst leading cause of cancer-related deaths in womenglobally1. Despite recent advances in breast cancer diag-
nosis and treatment, the mortality rate remains high due to the
regional and distant dissemination after the primary tumor
resection and the failure of the current anti-tumor therapies in
inhibiting metastasis. There is an urgent unmet need to under-
stand the molecular players and the regulatory mechanisms
involved in the metastasis of breast cancer and develop better
therapeutic strategies to block metastasis.
ULK1 (Unc-51-like kinase 1), an evolutionarily conserved
serine/threonine kinase, plays a central role in the autophagy
pathway to redirect cellular resources in response to stress2–4.
ULK1 was recently linked to the metastasis of several types of
tumors, such as non-small-cell lung cancer, esophageal squamous
cell carcinoma, and breast cancer5–8. The phosphorylation of
ULK1 on Ser757 inactivates ULK1, and is correlated with poor
survival in non-small-cell lung cancer patients5. It was shown
that, under metabolic stress, ULK1 phosphorylates the focal
adhesion kinase (FAK) family interacting protein of 200 kDa
(FIP200), which subsequently leads to the inhibition of FAK-
directed tumor cell motility and metastasis in non-small cell lung
cancer5. In breast cancer, low expression of ULK1 was found to
associate with lymph node metastasis and poor patient survival7.
Suppression of autophagy in the hypoxic tumor microenviron-
ment, using hypoxia-induced expression of the dominant-
negative mutant of ULK1 or ATG4B, increased fibronectin
deposition and facilitated breast cancer cell migration8. However,
the role of ULK1 and the mechanisms involved in the regulation
of breast cancer metastasis are still poorly understood.
The exocyst is an evolutionarily conserved octameric complex
consisting of Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70, and
Exo84. The exocyst mediates the tethering of secretory vesicles to
the plasma membrane during exocytosis9–12. Recently, a role for
the exocyst in cell migration and invasion has been reported13–24.
The exocyst subunit Exo70 interacts with the Arp2/3 complex, a
key nucleator of actin assembly, and enhances its binding to the
nucleation-promoting factor WAVE2, thereby promoting lamel-
lipodia formation and directionally cell migration17,21,25.
Knocking down endogenous Exo70 in cancer cells significantly
decreased their invasion, owing to the weakened actin poly-
merization and a block in the secretion of matrix metalloprotei-
nases (MMPs)14,17,18,24. In addition to interacting with the Arp2/
3 complex, Exo70 proteins also form homopolymers that induce
membrane curvature for membrane protrusion formation25.
Here we report Exo70 as a direct phospho-target of ULK1.
Phosphorylation of Exo70 by ULK1 inhibits the metastasis of
breast cancer cells. Mechanistically, ULK1 phosphorylation of
Exo70 inhibits its homo-oligomerization and assembly into the
exocyst complex, thereby blocking the formation of cell protru-
sion and the secretion of MMPs. Interestingly, the inhibitory
phosphorylation by ULK1 is counteracted by extracellular
signaling-regulated kinase (ERK), which phosphorylates Exo70 at
a different site upon growth factor signaling. Our study delineates
a molecular pathway by which ULK1 regulates tumor invasion
through direct phosphorylation of Exo70, and also reveals a
counteractive regulatory mechanism that functions during tumor
invasion.
Results
ULK1 inhibits breast cancer metastasis. To investigate the role
of ULK1 in breast cancer metastasis, we examined the expression
level of ULK1 in several human breast cancer cell lines with
different metastatic potential. ULK1 expression was lower in the
highly metastatic cell lines (MDA-MB-231 and BT-549) than
those in the low metastatic cell lines (MCF-7, MDA-MB-453, and
Bcap-37) (Fig. 1a), suggesting that ULK1 expression is negatively
correlated to the metastatic potentials of human breast cancer
cells. We then analyzed the effect of ULK1 on invasion. Over-
expression of ULK1, but not the kinase-dead mutant, ULK1
(M92A)26, significantly inhibited migration and invasion of the
metastatic MDA-MB-231 cells without affecting their growth or
survival during the observed period (Fig. 1b, c and Supplementary
Fig. 1a, b). Moreover, overexpression of ULK1 but not ULK1
(M92A) significantly inhibited invadopodium-mediated matrix
degradation by MDA-MB-231 cells (Fig. 1d, e). Reversely,
knocking down ULK1 in the low metastatic cell line MCF-7
increased its invasion and migration ability as indicated by the
transwell assay and wound healing assay (Fig. 1f–i and Supple-
mentary Fig. 1c–e).
Exo70 interacts with and is phosphorylated by ULK1. To
investigate how ULK1 suppresses breast cancer metastasis,
immunoprecipitation (IP) assay in cells expressing HA-tagged
ULK1 was carried out. Candidate ULK1-interacting proteins co-
precipitated with HA-ULK1, but not in that of the vector control,
were analyzed by mass spectrometry (MS). Exo70, a subunit of the
exocyst complex, was identified in the assay. The ULK1-Exo70
interaction was first confirmed by IP assays using tagged proteins
exogenously expressed in cells (Fig. 2a) and then with endogenous
proteins in different breast cancer cell lines including MDA-MB-
231 and MCF-7 (Fig. 2b). Furthermore, bacterially expressed GST-
Exo70 binds to purified HA-ULK1 (Fig. 2c). Co-localization of
ULK1 with Exo70 in dynamic actin filament networks critical for
membrane trafficking and remodeling as indicated by cortactin
counterstaining was observed by immunofluorescence microscopy
in MCF-7 and MDA-MB-231 cells (Fig. 2d).
We next investigated whether ULK1 phosphorylates Exo70.
When cells were cultured in starvation medium or treated with
rapamycin, ULK1 was activated as indicated by the decreased
phosphorylation levels of ULK1 on Ser757. The levels of
threonine/serine phosphorylation of endogenous Exo70 increased
(Fig. 3a). In additi on, overexpression of ULK1 in cells grown in
full medium27 increased the phosphorylation of Exo70 (Fig. 3b).
To determine whether ULK1 directly phosphorylates Exo70, we
conducted in vitro assay using recombinant Exo70 and purified
ULK1. Exo70 was phosphorylated by ULK1, but not the kinase-
dead ULK1(M92A) mutant protein (Fig. 3c). Together, these data
strongly suggested that Exo70 is a phospho-substrate of ULK1.
Next, the ULK1 phosphorylation sites in Exo70 were analyzed.
Exogenous Exo70 was purified by IP in ULK1 overexpression
cells, and then subjected to MS. Ser89 of Exo70 was identified as a
potential ULK1 phosphorylation site (Fig. 3d). The Exo70(S89A)
mutant was then generated and expressed alone or with ULK1 in
293T cells. The S89A mutation dramatically diminished, but not
eliminated, the phosphorylation of Exo70 induced by ULK1
(Fig. 3e), suggesting that Ser89 was indeed crucial for ULK1 to
phosphorylate Exo70, but some other ULK1-phosphorylated sites
on Exo70 also exist. According to the consensus ULK1-substrate
motif28, three other possible ULK1-phosphorylated sites (Ser47,
Ser59, and Ser194) were identified at the N terminus of Exo70
(Fig. 3f). ULK1-induced phosphorylation of Exo70 was moder-
ately suppressed by the single-point mutants S47A or S59A, but
not S194A (Fig. 3e). Moreover, Exo70 phosphorylation by ULK1
was greatly suppressed by the double mutant S47A/S59A. Triple
mutation on Exo70 (Exo70-3A: S47A/S59A/S89A) blocked its
phosphorylation (Fig. 3e). The in vitro phosphorylation assays
demonstrate that Ser47, Ser59, and Ser89 were responsible for the
phosphorylation of Exo70 directly catalyzed by ULK1 (Fig. 3g).
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Ser47, Ser59, and Ser89, with their flanking sequences, are highly
conserved in eukaryotic cells (Supplementary Fig. 2).
ULK1 phosphorylation of Exo70 inhibits metastasis. To test
whether ULK1 suppresses breast cancer metastasis through
phosphorylating Exo70, we analyzed the effect of Exo70 phos-
phorylation at Ser47, Ser59, and Ser89 on breast cancer
metastasis. Three phospho-mimetic single mutants (Exo70-S47D,
Exo70-S59D, and Exo70-S89D, respectively) and a triple mutant
(Exo70-3D: S47D/S59D/S89D) were constructed and transfected
individually into Exo70-knockdown MDA-MB-231 cells. Results
from both transwell assay and wound healing assay showed that
knockdown of Exo70 significantly decreased invasion and
migration of MDA-MB-231 cells, and the effect was rescued by
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Fig. 1 ULK1 inhibited migration and invasion of breast cancer cells. a The levels of ULK1 expression in breast cancer cell lines of different metastasis
ability were examined by western blotting. β-Actin was used as a loading control. b, c Effects of ULK1 and ULK1(M92A) on the migration and invasion of
MDA-MB-231 cells. Transwell assay was carried out using cells transfected with empty vector, HA-ULK1, or HA-ULK1(M92A) plasmid. Representative
images (scale bar: 100 μm) (b) and cell counts (c) were shown (n= 6 biologically independent samples). AU: arbitrary unit; I/M: ratio of invasion (I) to
migration (M). d, e Overexpressed ULK1 but not ULK1(M92A) significantly inhibited the degradation of extracellular matrix by MDA-MB-231 cells.
Representative images (d) and gelatin degradation levels from 45 cells (e) for each group were shown (n= 3 independent experiments). Scale bar: 10 μm.
f–i ULK1 knockdown increased the invasion and migration ability of MCF-7 cells as examined by the transwell assay (f, g) (scale bar: 100 μm) and wound
healing assay (h, i) (scale bar: 200 μm). Representative images (f, h), cell counts (g), and quantification of wound distance (i) were shown (n= 6
biologically independent samples for f, g, n= 5 biologically independent samples for h, i). Data represented the means ± SEM. P values were analyzed by
unpaired two-tailed Student’s t test and Kruskal–Wallis test (e).
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Fig. 2 Exo70 interacts with ULK1. a Interaction of Exo70 and ULK1 in 293T cells was detected by co-immunoprecipitation assay. Whole-cell lysates
(WCLs) and immunoprecipitated (IP) proteins were analyzed by western blotting. b The interaction of endogenous Exo70 with ULK1 in MCF-7 and MDA-
MB-231 cells were examined by co-immunoprecipitation using anti-Exo70 or anti-IgG (negative control) antibody. c The interaction of Exo70 and ULK1 was
determined by GST pull-down assay. Purified HA-ULK1 protein was incubated with recombinant GST-Exo70 protein conjugated to the Glutathione
Sepharose. GST-Exo70 was examined by Coomassie Blue staining (lower panel) and the bounded HA-ULK1 was detected with anti-HA antibody (upper
panel). GST was used as a negative control. d The co-localization of endogenous Exo70, ULK1, and cortactin was demonstrated with immunofluorescence
in MCF-7 and MDA-MB-231 cells. Scale bar: 10 μm.
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re-introducing the wild-type (WT) Exo70 (rat Exo70, which is
not targeted by human shExo70). The expression of the single-
point mutant S47D, S59D, or S89D, or the Exo70-3D triple
mutant either partially or failed to rescue the inhibitory effect
(Fig. 4a–d and Supplementary Fig. 3a). To further test the effect
of ULK1-mediated Exo70 phosphorylation on cell migration and
invasion, we carried out rescue experiments with the phospho-
deficient Exo70-3A mutant. Overexpression of ULK1 inhibited
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Fig. 3 Exo70 is phosphorylated by ULK1 on Ser47, Ser59, and Ser89. a The level of threonine/serine phosphorylation of endogenous Exo70 under
starvation conditions or rapamycin treatment. MDA-MB-231 cells were placed in starvation medium (EBSS, HBSS, or DMEM medium sugarless) or treated
with rapamycin (50 nM) for 2 h, and then subjected to immunoprecipitation using anti-Exo70 antibody. Whole-cell lysates (WCLs) and
immunoprecipitated (IP) proteins were analyzed by western blotting. Threonine/serine phosphorylation on Exo70 was detected by anti-p-Ser/Thr
antibody. b 293T cells were transfected with empty vector or HA-ULK1 plasmid, and immunoprecipitation assay was carried out with anti-Exo70 antibody.
Overexpression of ULK1 (HA-ULK1) increased the threonine/serine phosphorylation of endogenous Exo70 protein. c In vitro phosphorylation of Exo70 by
ULK1. Bacterially purified Exo70 was incubated with purified HA-ULK1 and HA-ULK1(M92A) in the in vitro phosphorylation assay as described in Materials
and methods. d Potential ULK1-phosphorylated sites within the N terminus of Exo70 based on the consensus ULK1 phospho-substrate sequence. e Effects
of Exo70 mutations on its phosphorylation induced by ULK1. HA-ULK1 was co-transfected with the indicated FLAG-Exo70 plasmids in 293T cells, and then
subjected to immunoprecipitation with anti-Flag antibody. Phosphorylation of Exo70 at serine/threonine was examined with p-Ser/Thr antibody. f Ser89
was identified to be another potential ULK1-phosphorylated site using immunoprecipitation in combination with mass spectrometry (IP-MS). g In vitro
phosphorylation of wild-type and mutant Exo70 by purified ULK1. Exo70 at serine/threonine was examined with p-Ser/Thr antibody.
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the migration and invasion of Exo70-knockdown MDA-MB-231
cells, which express Exo70-WT but not Exo70-3A (Supplemen-
tary Fig. 3c). During the period of assay, cell number did not
show significant difference among all the groups (Supplementary
Fig. 3b, d).
To study the effect of ULK1 phosphorylation in vivo,
metastasis assay was carried out in mice. Four MDA-MB-231
cell lines stably expressing Exo70-WT, Exo70-3D, Exo70-3A, or a
control vector were injected into the tail vein of nude mice, and
the pulmonary metastasis of these groups was detected and
compared 4 weeks later using bioluminescence analysis. Over-
expression of Exo70-WT and Exo70-3A, but not Exo70-3D,
significantly promoted the pulmonary metastasis of breast cancer
cells when compared to the control group. Notably, the Exo70-3A
group had significantly higher level of metastasis even when
compared to the Exo70-WT group (Fig. 4e, f and Supplementary
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Fig. 3e). No significant difference in the growth of xenograft
tumors for these four cell lines was detected (Supplementary
Fig. 3f–g). These data thus suggest that ULK1 phosphorylation of
Exo70 inhibits breast cancer metastasis.
ULK1 phosphorylation inhibits Exo70 oligomerization. It was
previously shown that the homo-oligomerization of Exo70 led to
the induction of membrane protrusions and directional cell
migration25. The hetero-oligomerization of Exo70 with the other
exocyst subunits is also needed for the secretion of MMPs,
including MMP-2 and MMP-918,24. We thus analyzed whether
Exo70 phosphorylation on Ser47, Ser59, and Ser89 influences its
ability to form homopolymers or to bind other exocyst subunits.
Co-IP assay showed that the self-interaction of Exo70 proteins
was suppressed when they were co-expressed with ULK1
(Fig. 5a). The ability of Exo70 proteins to self-assemble increased
when Ser47, Ser59, and Ser89 were mutated to alanine alone or in
combination, and this effect was no longer able to be suppressed
by the co-expression of ULK1 (Fig. 5a). Consistently, the single-
point mutant S89D and the double mutants S47D/S89D and
S59D/S89D partially inhibited the self-association of Exo70,
whereas the triple mutant Exo70-3D was almost incapable of self-
association (Fig. 5b, both Exo70-Flag and HA-Exo70 were
mutated). The potential oligomerization of recombinant Exo70-
WT and Exo70-3D was also examined by gel-filtration chroma-
tography. Compared to Exo70-WT, the peak fraction of Exo70-
3D shifted to the lower-molecular weight fractions (Fig. 5c, d). It
was previously shown that oligomerization of Exo70 induces
membrane protrusions on the cell surface17,20,23. We then
investigated whether Exo70 phosphorylation by ULK1 affects
membrane protrusion formation. Using fluorescence microscopy,
we compared the formation of membrane protrusions after
expressing GFP-tagged Exo70 variants in MDA-MB-231 cells. As
shown in Fig. 5e, f, Exo70-WT and Exo70-3A induced much
more protrusions than Exo70-3D.
Using IP assay, we also found that the interactions of Exo70-
3D with several other exocyst subunits, including Sec6, Sec8, and
Exo84, were markedly decreased (Fig. 5g). We also tested the
effect of Exo70 or its mutants on MMPs secretion in MDA-MB-
231 cells using zymography. Cells transfected with Exo70-WT
showed a significant increase of MMP-9 secretion, whereas cells
expressing Exo70-3D showed mildly reduced MMP-9 secretion
when compared to the vector control (Fig. 5h).
Exo70-Ser89 phosphorylation in human breast cancer tissues.
ULK1 expression was negatively associated with breast cancer
progression and is a prognostic marker for breast cancer7. Since
our data showed that Exo70 phosphorylation by ULK1 inhibited
breast cancer metastasis, we investigated the relationship between
ULK1 expression and the phosphorylation levels of Exo70 in
clinical breast cancer tissues. For this aim, we attempted to
generate antibodies that bind specifically to one of these three
phosphorylation sites. However, only the anti-phospho-Exo70
(Ser89) antibody was successfully obtained (Supplementary
Fig. 4a). We also tested whether this antibody was specific at the
cellular level, using overexpressed and endogenous Exo70 pro-
teins. Plasmids expressing Exo70-WT, Exo70-Ser47A, or Exo70-
Ser89A was transfected alone or together with ULK1 into
293T cells, and the whole-cell lysates were subjected to western
blot analysis. The antibody recognized ULK1-induced phos-
phorylation of both endogenous Exo70 and overexpressed Exo70-
WT and Exo70-Ser47A, but not Exo70-Ser89A (Supplementary
Fig. 4b). Moreover, ULK1-induced phosphorylation level of
endogenous Exo70, detected using this antibody, was greatly
attenuated after knocking down endogenous Exo70 (Supple-
mentary Fig. 4c).
The relationship between ULK1 expression and the phosphor-
ylation level of Exo70 on Ser89 in clinical breast cancer tissues
was then examined using a commercial ULK1 antibody and our
anti-phospho-Exo70-Ser89 antibody. As shown in Fig. 5i, the
phosphorylation level of Exo70 on Ser89 was significantly
decreased in human invasive breast cancer tissues as compared
to the adjacent normal tissues, and was positively correlated with
the expression level of ULK1.
Exo70 phosphorylation by ULK1 is suppressed by ERK1/2. We
have previously shown that phosphorylation of Exo70 on Ser250
by ERK1/2 stimulates cell invasion by promoting the interaction
of Exo70 with the other exocyst components, which in turn leads
to enhanced invadopodia formation and MMP secretion18. We
then asked whether ERK1/2 phosphorylation affects Exo70
phosphorylation by ULK1. As shown in Fig. 6a, phosphorylation
of Exo70 on Ser89 by ULK1 was inhibited after epidermal growth
factor (EGF) treatment; the inhibitory effect was attenuated by
the addition of PD98059, an inhibitor of ERK1/2. Consistent with
this observation, the level of ULK1-induced phosphorylation on
Ser89 decreased in the Exo70(S250D) mutant, which was shown
to mimic S250 phosphorylation by ERK18 (Fig. 6b). The S250D
mutation also decreased the binding of Exo70 to ULK1 (Fig. 6c).
These results suggest that ULK1 phosphorylation of Exo70 is
inhibited by ERK1/2 phosphorylation of Exo70 on Ser250 in
response to growth factor signaling.
Discussion
ULK1 expression was recently linked to breast cancer metastasis7.
In this study, we demonstrated that ULK1 suppressed the
migration and invasion of human breast cancer cells. We have
identified Exo70, a key component of the exocyst complex
essential for cell motility and invasion18,24, as a direct ULK1
downstream phospho-substrate. ULK1 phosphorylation of Exo70
on Ser47, Ser59, and Ser89 led to the suppression of breast cancer
cell migration and invasion. We have generated a specific anti-
phospho-Exo70 (Ser89) antibody, and showed that Exo70 phos-
phorylation on Ser89 was significantly decreased in human breast
Fig. 4 Phosphorylation of Exo70 on Ser47/59/89 inhibited breast cancer metastasis. a–d Exo70 phosphorylation on Ser47, Ser59, and Ser89 inhibited
the migration and invasion of MDA-MB-231 cells as analyzed by transwell assay (a, b) (scale bar: 100 μm) and wound healing assay (c, d) (scale
bar: 200 μm). Control (Scramble) and Exo70 shRNA knockdown cells were transfected with empty vector, Exo70-Flag or Exo70 mutant variants.
Representative images (a, c), cell counts (b), and quantification of wound distance (d) were shown (n= 6 biologically independent samples for a, b, n= 3
biologically independent samples for c, d). AU: arbitrary unit. e, f Exo70 phosphorylation on Ser47, Ser59, and Ser89 suppressed the metastasis of MDA-
MB-231 cells to the lung. MDA-MB-231 cells stably expressing empty vector, Exo70-Flag, Exo70(3D)-Flag, or Exo70(3A)-Flag were subjected to tail-vein
injection into nude mice (vector n= 6, WT n= 6, 3D n= 8, 3A n= 5). Representative images (e) and quantification (f) of Luciferase expression within the
lungs of nude mice in each group were shown. Data represented the mean ± SEM. The difference in significance was analyzed by one-way analysis of
variance (ANOVA) (b, d) or unpaired two-tailed Student’s t test (f no adjustment was made for multiple comparisons). *P < 0.05; **P < 0.01; ***P < 0.001;
and n.s., nonsignificant vs. the indicated control.
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cancer tissues compared to the paired adjacent normal tissues.
The level of Exo70-Ser89 phosphorylation positively correlated
with the expression level of ULK1. Together, these results
demonstrated that ULK1 mediates the phosphorylation and
inactivation of Exo70, resulting in the suppression of breast
cancer cell motility and metastasis.
Mechanistically, we demonstrate that phosphorylation of
Exo70 inhibits its homo-oligomerization and its interaction with
other exocyst subunits, which are required for cell surface pro-
trusion formation and MMP secretion during invasion25. The
ULK1 phosphorylation sites, Ser47, Ser59, and Ser89, are located
to the N terminus of Exo70, a region that was previously shown
to be involved in its homo-oligomerization25. Our recent cryo-
electron microscopy study in yeast indicates that the N-terminal
CorEx motif of Exo70, which is conserved from yeast to human,
is responsible for its interaction with Exo84, Sec10, Sec15, and
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other subunits to form the intact exocyst complex29. The pre-
diction on the secondary structure showed an α-Helix exist in
amino acids 5–102, which included the ULK1 phosphorylation
sites29. The phosphorylation of Exo70 on these residues may
bring in electrostatic charges or disrupt the proper conformation
of α-helix that destabilize these interactions, thereby affecting the
homo-oligomerization and the assembly of the exocyst complex.
Opposite to the inhibitory phosphorylation by ULK1, our
previous work demonstrated that Exo70 can be phosphorylated
by ERK1/2 in response to growth factors such as EGF, thereby
promoting cell invasion18. Our present study demonstrates that
Exo70 phosphorylation on Ser250 by ERK1/2 suppressed ULK1-
mediated phosphorylation of Exo70. We propose a model that,
under stress condition, ULK1 is activated and suppresses Exo70
to keep breast cancer cells dormant. However, under conditions
such as growth factor stimulation, Exo70 is phosphorylated by
ERK on S250. The phosphorylation of Exo70 on S250 not only
promotes exocyst assembly but also blocks the inhibitory phos-
phorylation by ULK1, which may sustain cell invasion for
metastasis (Fig. 6d).
Our finding provides a mechanism that regulates tumor cell
invasion, and may potentially lead to the development of tools for
prognosis and therapeutic treatment of breast cancer.
Methods
Cell culture. Human embryonic kidney cell line 293T (Cat. #GNHu17), human
breast cancer cell lines MDA-MB-231 (Cat. #TCHu227), MCF-7 (Cat. #SCSP-531),
and MDA-MB-453 (Cat. #TCHu233) were obtained from the Institute of Cell
Biology, Shanghai, China. Human breast cancer cell lines Bcap-37 and BT-549
were kindly provided by Professor Bo-an Li (Xiamen University, Xiamen, Fujian,
China). The 293T, MDA-MB-231, and MCF-7 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco, Grand Island, NY, USA). MDA-MB-453
cells were maintained in Leibovitz’s L-15 medium (Gibco, Grand Island, NY, USA).
Bcap-37 and BT-549 cells were maintained in RPMI-1640 medium (Gibco, Grand
Island, NY, USA). All media were supplemented with 10% fetal bovine serum (FBS,
HyClone, Logan, UT, USA), 100 Uml−1 penicillin and 100 μg ml−1 streptomycin
(Life Technologies, Carlsbad, CA, USA). Cells were cultured at 37 °C in humidified
incubator containing 5% CO2. All cell lines were identified by STR (Short Tandem
Repeat) profiling by the source. Cells were expanded after being received and
subsequently stored in liquid nitrogen. The storage vials were thawed for experi-
ments and used in <2 months. All cell lines were confirmed negative for myco-
plasma. For starvation condition, Earle’s balanced salt solution (EBSS), Hank’s
balanced salt solution (HBSS), and DMEM medium sugarless were used.
IP, western blot, and dot-blot analyses. Cells were lysed in ice-cold lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 100 mM NaF, 1% Triton X-100, 2 mM
EDTA, 40 mM β-glycerolphosphate, 1 mM sodium orthovanadate, 1 μg ml−1 leu-
peptin, 1 μg ml−1 pepstin, 1 µg ml−1 aprotinin, and 1 mM phenylmethylsulfonyl
fluoride), sonicated five times for 3 s each, and centrifuged at 16,000 × g for 15 min
at 4 °C. The protein concentration of the supernatant was measured by BCA
protein assay kit (Thermo Scientific, Rockford, IL, USA). For IP or co-IP, cell
lysates were incubated with antibodies overnight at 4 °C. Protein A/G plus-agarose
beads (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added into the
lysates and incubated for 3 more hours. Beads were then washed three times in lysis
buffer and then boiled. For western blotting, the boiled samples were run on
sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE) and transferred onto
ImmobilonTM-P PVDF membranes (Merck Millipore, Billerica, MA, USA). After
blocking with 5% skim milk in phosphate-buffered saline with 0.1% Tween-20 for
1 h, the membranes were incubated with antibodies. Immunoreactive bands were
detected using Enhanced Chemiluminescence (ECL) system (Bio-Rad, Hercules,
CA, USA). For dot blotting, 1–2 μl antigen was spotted onto a piece of membrane,
left dry for 30 min or longer, and then blocked and incubated with antibody and
the blots were detected as described above.
Clinical tissue analysis. Clinical sample study was approved by the Medical Ethics
Committee of Zhongshan Hospital Affiliated to Xiamen University in accordance
with the Declaration of Helsinki and conducted with the informed consent of all
patients. All breast tissue samples were obtained from the tissue bank of Zhong-
shan Hospital Affiliated to Xiamen University. All these five cases are invasive
breast carcinomas that correspond to different subtypes. Case 2 and case 3 are
triple-negative (ER-negative, PR-negative, and HER-2-negative); cases 1 and 5 are
luminal A (ER- and PR-positive); case 4 is HER-2-enriched (ER- and PR-negative,
HER-2-positive). Tissue samples were homogenized and lysed in ice-cold lysis
buffer as described above and subjected to western blotting.
GST pull-down assay. For GST pull-down assay, HA-ULK1 proteins were over-
expressed in 293T cells and immunoprecipitated with anti-HA antibody and
protein A/G plus-agarose beads as described in IP assay, and then eluted with HA
peptide. Recombinant GST-Exo70 protein was expressed in Escherichia coli, and
then purified and conjugated to glutathione sepharose, which was further incu-
bated with the purified HA-ULK1 proteins in ice-cold lysis buffer at 4 °C for 3 h.
Beads were then washed three times in lysis buffer and boiled, and the samples
were then subjected to western blotting.
In vitro phosphorylation assay. For in vitro phosphorylation assay, HA-ULK1,
HA-ULK1(M92A), GST-Exo70, and its mutant variants were purified. The purified
Exo70 proteins (without GST-tag) were released from the glutathionesSepharose
beads by incubation with thrombin (Cat. #T4648, Sigma-Aldrich, St. Louis, MO,
USA) overnight at 4 °C.
Prepared Exo70 or its mutants (without GST-tag) together with the HA-ULK1
or HA-ULK1(M92A) proteins, as mentioned above, were then added into the
kinase buffer (25 mM HEPES, pH 7.4, 50 mM NaCl, 5 mM MgCl2, 1 mM
dithiothreitol (DTT), 0.5 mg ml−1 bovine serum albumin, 200 μM ATP) and
incubation at 30 °C for 1 h. Samples were then processed for western blotting.
Transwell assay. Cells (5 × 104) were plated on 8.0-μm pore size Boyden chambers
(Millipore Corp., Billerica, MA, USA), either coated with bovine collagen I (Tre-
vigen, Gaithersburg, MD, USA, for invasion assays) or uncoated (for migration
assays), in serum-free medium containing 10 g l−1 bovine serum albumin. Medium
containing 10% FBS was used as a chemoattractant in the lower chamber. After
incubation at 37 °C for 12 h for migration assay and 18 h for invasion assay, the
non-invaded or non-migrated cells were removed from the upper face of the
transwell membrane using cotton swabs. The migrated or invaded cells were fixed
with 4% paraformaldehyde and stained using 0.1% crystal violet in methanol, and
then counted in randomly selected fields under a light microscope.
Wound healing assay. Cells were grown to a confluent monolayer in a six-well
tissue culture dish. Cell monolayers were wounded using a sterile p200 pipette tip,
and then washed twice with phosphate-buffered saline (PBS) to remove cell debris
and incubated in medium with 1% FBS. Cell migration was monitored under an
inverted microscope equipped with a camera. The wound distance (width) at
different time point was measured. The wound open (%)=wound distance/
AWD0 × 100; AWD0: average wound distance at 0 h.
Fig. 6 ULK1 phosphorylation of Exo70 was suppressed by ERK1/2 phosphorylation. a ULK1 phosphorylation of Exo70 on Ser89 was affected by EGF and
PD98059 treatment. The 293T cells transfected with ULK1-Flag and/or HA-Exo70 as indicated were treated with EGF or PD98059. The cell lysates were
then subjected to immunoprecipitation with anti-HA antibody. Phosphorylation of Exo70 at Ser89 was examined by the anti-pSer89 antibody and
quantified by densitometry. Data represented the mean ± SEM (n= 3, three independent experiments), and the P values were analyzed by unpaired two-
tailed Student’s t test. b ULK1 phosphorylation of Exo70 on Ser89 was lower than that of Exo70(S250D). The 293T cells were co-transfected with ULK1-
Flag and HA-Exo70 or HA-Exo70(S250D), and then subjected to immunoprecipitation with anti-HA antibody. Phosphorylation of Exo70 at Ser89 was
examined by the anti-pSer89 antibody. c The interaction of ULK1 with Exo70(S250D) was compared with that of ULK1 and wild-type Exo70 by co-
immunoprecipitation assay. d Regulation of Exo70 by ULK1 and ERK1/2 under different growth condition. Upon energy stress, ULK1 was activated and
phosphorylated Exo70 on Ser47, Ser59, and Ser89, subsequently inhibiting the self-oligomerization of Exo70 and its interaction with other exocyst
subunits; thereafter, decreasing filopodial protrusions formation and MMP secretion, which led to the suppression of breast cancer cell migration and
invasion. Under growth stimuli, activated ERK1/2 phosphorylated Exo70 on Ser250, which facilitates cell invasion via enhancing the interaction of Exo70
with other exocyst subunits and thus increasing invadopodia formation and MMP secretion (our published data18); additionally, Exo70 phosphorylation on
Ser250 by ERK1/2 could also suppressed ULK1-induced phosphorylation of Exo70 to release metastasis inhibition.
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In vivo tail vein metastasis assay. MDA-MB-231 cell sublines stably expressing
luciferase (1 × 106 cells per mouse) were injected into the tail vein of 5-week-old
female nude mice. After 4 weeks, mice were imaged on the ventral side for luci-
ferase expression via Caliper IVIS Lumina II. Five minutes before imaging, mice
were injected intraperitoneally with 200 μl of 10 mgml−1 D-luciferin (Promega,
Cat. #E1605) in PBS and then imaged with a Caliper IVIS Lumina II Kinetic
system. Total photon flux of the ventral thoracic area was measured and analyzed
using the ROI tool in Living Image 4.4 software for lung metastasis. All animal
experiments were performed in accordance with protocol approved by the Animal
Care and Use Committee of Xiamen University.
Extracellular matrix degradation assay. The coverslips (20 mm) were coated
with 0.01% poly-L-lysine solution (Sigma-Aldrich, Cat. #P8920) and fixed with
0.5% glutaraldehyde for 15 min. The coverslips were inverted onto 80-μl droplets of
gelatin matrix (0.2% gelatin and Alexa Fluor 488-labeled gelatin (Molecular Probes,
Cat. #G-13186) at an 8:1 ratio) for 15 min and incubated in 5 mgml−1 of NaBH4
(Sigma-Aldrich) for 15 min, followed by extensive washing with Dulbecco’s PBS
(Gibco). Finally, the plate was incubated in DMEM for 1 h at 37 °C before adding
the cells.
To examine the ability of cells to degrade matrix, 2 × 104 MDA-MB-231 cells
expressing HA-ULK1 or HA-ULK1(M92A) were plated onto the coverslips and
incubated at 37 °C for 20 h, and processed for immunofluorescence. HA-ULK1 or
HA-ULK1(M92A) were stained with mouse anti-HA (Cat. #H9658, 1:500),
followed by Cy3-conjugated goat anti-mouse IgG secondary antibody (Cat. #115-
165-003, 1:300), and F-actin was stained by anti-Phalloidin-iFuor 647 conjugate
antibody (Cat. #ab176759, 1:300). The matrix degradation index was analyzed by
Image J (National Institutes of Health, Bethesda, MD, USA). For quantification, the
degradation level of each cell was measured as the area of the degraded zones
normalized to the area of the entire field, and then the percentage of cells with
different degradation levels was calculated.
In-gel zymography. Cells were cultured in serum-free DMEM for 24 h, and the
medium were collected and concentrated. Samples were then separated on an 8%
SDS-PAGE gel containing 1 mgml−1 gelatin. The gel was washed twice in washing
buffer (2.5% Triton X-100 in H2O), incubated in developmental buffer (50 mM of
Tris-HCl, pH 7.6, and 5 mM of CaCl2) at 37 °C for 48 h and stained with Coo-
massie Blue. The clear bands indicate where MMPs degraded gelatin. Gel loading
was normalized to the total proteins.
Gel filtration. Four hundred microliters (800 μg) of recombinant Exo70 or Exo70
(3D) mutant was loaded onto a pre-equilibrated Superdex 200 10/300GL column
and eluted with PBS containing 1 mM DTT at a flow rate of 0.5 ml min−1. Five
hundred microliters of fractions were collected. Twenty microliters of each fraction
was subjected to 10% SDS-PAGE and stained with Coomassie Blue.
MS analysis of Exo70 phosphorylation. Exogenous Exo70-Flag, co-
overexpressed with HA-ULK1 or the empty vector in 293T cells (cultured in full
medium), was immunoprecipitated with anti-Flag antibody and protein A/G-
agarose as mentioned in IP assay. Immunoprecipitated samples were run on SDS-
PAGE and stained with Coomassie Blue. For liquid chromatography-mass spec-
trometer (LC-MS)/MS analysis, the Exo70 samples in the SDS-PAGE were excised
and digested with trypsin overnight and the peptides were separated by a 120 min
gradient elution at a flow rate of 0.30 µl min−1 with a Dionex Ultimate 3000 HPLC
system (Thermo Fisher Scientific, Waltham, MA, USA), which is directly interfaced
with a Q Exactive mass spectrometer (Thermo Fisher Scientific, Waltham, MA,
USA). The analytical column was a home-made fused silica capillary column
(75 µm ID, 150 mm length; Upchurch, Oak Harbor, WA, USA) packed with C-18
resin (300 Å, 5 µm, Varian, Lexington, MA, USA). Mobile phase consisted of 0.1%
formic acid, and mobile phase B consisted of 80% acetonitrile and 0.1% formic
acid. The Q Exactive mass spectrometer was operated in the data-dependent
acquisition mode using the Xcalibur 2.1.2 software (Thermo Fisher Scientific,
Waltham, MA, USA) and there was a single full-scan mass spectrum in the
orbitrap (300–1800m/z, 70,000 resolution), followed by 20 data-dependent MS/MS
scans at 27% normalized collision energy (HCD). The MS/MS spectra from each
LC-MS/MS run were searched against the Rat.fasta from Uniprot using an in-
house Proteome Discoverer (Version PD1.4, Thermo Fisher Scientific, Waltham,
MA, USA). The search criteria were as follows: two missed cleavage was allowed;
phosphorylation was set as the variable modification. The PhosphoRS algorithm
was used to calculate the probability of the phosphorylation sites. When the
PhosphoRS probability was above 75%, the phosphorylation site was considered to
be authentic.
Statistics and reproducibility. All results were presented as means ± SEM. The
statistical details including the definitions and value of n (e.g., number of experi-
mental replicates, micrographs, cells, animals, etc.) were provided in the figures and
corresponding figure legends. All gels and blots were representative of three
independent experiments. Statistical significance was determined by two-tailed
unpaired Student’s t test or one-way analysis of variance using GraphPad Prism 6
(GraphPad Software), or Kruskal–Wallis test using the SPSS 19 software.
Other methods. Detailed descriptions of the other methods used in this study,
including antibodies and reagents, plasmids, transient transfection, lentivirus-
mediated stable overexpression or knockdown, real-time PCR, immunofluorescent
staining, MTT assay, and tumor xenograft assay are provided in the Supplementary
Materials and Methods.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1–6 and Supplementary Figs. 1–4 are provided as a
Source Data file. All the other data supporting the findings of this study are available
within the article and its Supplementary information files and from the corresponding
author upon reasonable request.
Received: 28 November 2018; Accepted: 2 December 2019;
References
1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of
incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer
J. Clin. 68, 394–424 (2018).
2. Zachari, M. & Ganley, I. G. The mammalian ULK1 complex and autophagy
initiation. Essays Biochem. 61, 585–596 (2017).
3. Lin, M. G. & Hurley, J. H. Structure and function of the ULK1 complex in
autophagy. Curr. Opin. Cell Biol. 39, 61–68 (2016).
4. Mizushima, N. The role of the Atg1/ULK1 complex in autophagy regulation.
Curr. Opin. Cell Biol. 22, 132–139 (2010).
5. Caino, M. C. et al. Metabolic stress regulates cytoskeletal dynamics and
metastasis of cancer cells. J. Clin. Investig. 123, 2907–2920 (2013).
6. Jiang, L. et al. Association of the expression of unc-51-Like kinase 1 with
lymph node metastasis and survival in patients with esophageal squamous cell
carcinoma. Int. J. Clin. Exp. Med. 7, 1349–1354 (2014).
7. Tang, J. et al. Low expression of ULK1 is associated with operable breast
cancer progression and is an adverse prognostic marker of survival for
patients. Breast Cancer Res. Treat. 134, 549–560 (2012).
8. Dower, C. M., Bhat, N., Wang, E. W. & Wang, H. G. Selective reversible
inhibition of autophagy in hypoxic breast cancer cells promotes pulmonary
metastasis. Cancer Res. 77, 646–657 (2017).
9. TerBush, D. R. & Novick, P. Sec6, Sec8, and Sec15 are components of a
multisubunit complex which localizes to small bud tips in Saccharomyces
cerevisiae. J. Cell Biol. 130, 299–312 (1995).
10. Heider, M. R. & Munson, M. Exorcising the exocyst complex. Traffic 13,
898–907 (2012).
11. Wu, B. & Guo, W. The exocyst at a glance. J. Cell Sci. 128, 2957–2964 (2015).
12. Mei, K. & Guo, W. The exocyst complex. Curr. Biol. 28, R922–R925 (2018).
13. Zhu, Y., Wu, B. & Guo W. The role of Exo70 in exocytosis and beyond. Small
GTPases 10, 331–335 (2019).
14. Lu, H. et al. Oncogenic BRAF-mediated melanoma cell invasion. Cell Rep. 15,
2012–2024 (2016).
15. Monteiro, P. et al. Endosomal WASH and exocyst complexes control
exocytosis of MT1-MMP at invadopodia. J. Cell Biol. 203, 1063–1079 (2013).
16. Sakurai-Yageta, M. et al. The interaction of IQGAP1 with the exocyst complex
is required for tumor cell invasion downstream of Cdc42 and RhoA. J. Cell
Biol. 181, 985–998 (2008).
17. Zuo, X. et al. Exo70 interacts with the Arp2/3 complex and regulates cell
migration. Nat. Cell Biol. 8, 1383–1388 (2006).
18. Ren, J. & Guo, W. ERK1/2 regulate exocytosis through direct phosphorylation
of the exocyst component Exo70. Dev. Cell 22, 967–978 (2012).
19. He, B. & Guo, W. The exocyst complex in polarized exocytosis. Curr. Opin.
Cell Biol. 21, 537–542 (2009).
20. Liu, J. & Guo, W. The exocyst complex in exocytosis and cell migration.
Protoplasma 249, 587–597 (2012).
21. Liu, J. et al. Exo70 stimulates the Arp2/3 complex for lamellipodia formation
and directional cell migration. Curr. Biol. 22, 1510–1515 (2012).
22. Xiao, L. et al. Exo70 is an independent prognostic factor in colon cancer. Sci.
Rep. 7, 5039 (2017).
23. Biondini, M. et al. Direct interaction between exocyst and Wave complexes
promotes cell protrusions and motility. J. Cell Sci. 129, 3756–3769 (2016).
24. Liu, J., Yue, P., Artym, V. V., Mueller, S. C. & Guo, W. The role of the exocyst
in matrix metalloproteinase secretion and actin dynamics during tumor cell
invadopodia formation. Mol. Biol. Cell 20, 3763–3771 (2009).
25. Zhao, Y. et al. Exo70 generates membrane curvature for morphogenesis and
cell migration. Dev. Cell 26, 266–278 (2013).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13923-7 ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:117 | https://doi.org/10.1038/s41467-019-13923-7 | www.nature.com/naturecommunications 11
26. Jung, C. H. et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to
the autophagy machinery. Mol. Biol. Cell 20, 1992–2003 (2009).
27. Dunlop, E. A., Hunt, D. K., Acosta-Jaquez, H. A., Fingar, D. C. & Tee, A. R.
ULK1 inhibits mTORC1 signaling, promotes multisite Raptor
phosphorylation and hinders substrate binding. Autophagy 7, 737–747 (2011).
28. Egan, D. F. et al. Small molecule inhibition of the autophagy kinase ULK1 and
Identification of ULK1 substrates. Mol. Cell 59, 285–297 (2015).
29. Mei, K. et al. Cryo-EM structure of the exocyst complex. Nat. Struct. Mol. Biol.
25, 139–146 (2018).
Acknowledgements
This work was supported by the grants from the National Natural Science Foundation of
China (81572589, U1405228, 81472568, and 31770860), the Natural Science Foundation
of Fujian grant (2017J06020, 2018J01400, 2017R1036-4, 2017R1036-6, 2016R1034-1, and
2016R1034-4), and the Xiamen Science and Technology grant (3502Z20159013) to Y.-y.
Z. and T.H., and National Institute of Health R01 GM111128 to W.G.
Author contributions
Y.-y.Z., W.G., and T.H. designed the experiments and wrote the manuscript. L.M., Y.-y.Z,
B.W., Q.Y., L.X., X.H., L.Z., P.M., L.X., X.W., H.C., W.Z., B.C., J.X., K.M., and R.R.
carried out the experiments.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41467-
019-13923-7.
Correspondence and requests for materials should be addressed to Y.-y.Z., W.G. or T.H.
Peer review information Nature Communications thanks Jing Yang and the other,
anonymous, reviewer for their contribution to the peer review of this work.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2020
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13923-7
12 NATURE COMMUNICATIONS |          (2020) 11:117 | https://doi.org/10.1038/s41467-019-13923-7 | www.nature.com/naturecommunications
